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Abstract 
Quasi-experimental studies are increasingly used to establish causal relationships in 
epidemiology and health systems research. Quasi-experimental studies offer important 
opportunities to increase and improve evidence on causal effects: (i) they can generate 
causal evidence when randomized controlled trials are impossible; (ii) they typically generate 
causal evidence with a high degree of external validity; (iii) they avoid the threats to internal 
validity that arise when participants in non-blinded experiments change their behavior in 
response to the experimental assignment to either intervention or control arm (such as 
compensatory rivalry or resentful demoralization); (iv) they are often well-suited to generate 
causal evidence on long-term health outcomes of an intervention, as well as non-health 
outcomes such as economic and social consequences; and (v) they can often generate 
evidence faster and at lower cost than experiments and other intervention studies. 
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What’s new 
 
• Quasi-experiments are often seen as a second-best design option when experiments 
are not feasible. 
 
• Quasi-experiments are indeed often a good alternative to generating strong causal 
evidence, when experiments are not possible because of  
1. Ethical or political constraints to experimental assignment to intervention and 
control group 
2. Funding constraints 
3. Time constraints 
 
• However, quasi-experiments also have distinct advantages over experiments that 
can render them the first-best option in certain instances. These advantages include 
the following: 
1. Quasi-experiments can generate causal evidence with higher external validity 
than experiments, because they typically distort the context of an intervention 
less than experiments. 
2. Quasi-experiments avoid threats to internal validity that can arise when 
participants in non-blinded experiments change their behavior in response to 
the experimental assignment (such as compensatory rivalry or resentful 
demoralization) 
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Introduction 
Randomized controlled experiments are commonly considered the “gold standard” for causal 
evidence in health research [1]. Randomization of individuals to treatment and control 
groups ensures that treatment assignment is exogenous, i.e., no factor affecting the 
outcomes of interest can have exerted any influence on treatment assignment. As a result of 
randomization, selection bias in effect estimation is eliminated and the treatment and control 
group differ, in expectation, only in the treatment assignment. As corollary, all confounding 
factors, both observed and unobserved, are automatically balanced across treatment arms, 
and thus do not need to be separately controlled for in the estimation of causal effects of the 
treatment on outcomes.   
Traditionally, for evidence synthesis in health, randomized controlled trials (RCTs) have 
been considered the main type of study that is of sufficient strength in generating causal 
evidence to warrant inclusion in systematic reviews and meta-analyses. For instance, the 
Cochrane Collaboration used to assert that “[r]andomized trials are the preferred design for 
studying the effects of healthcare interventions because, in most circumstances, 
the randomized trial is the study design that is least likely to be biased,” while contending 
that exceptionally “review authors may be justified in including non-randomized studies,” if 
“the question of interest cannot be answered by randomized trials” [2]. More recently, 
however, the Cochrane Collaboration has started an initiative on “assessing risk of bias in 
non-randomised studies” (ROBINS-I), which it plans to extend in the future to “specific types 
of NRSI [non-randomised studies of interventions], such as self-controlled designs, 
controlled before-and-after studies, interrupted time series studies, and studies based on 
regression discontinuity and instrumental variable analyses“ [3]. The specific types of studies 
mentioned in this quote are sometimes referred to as quasi-experiments because – like 
experiments – they offer a strategy to circumvent the bias that can arise from participants’ 
endogenous selection into different treatment arms, i.e., selection based on factors that also 
affect the outcomes of interest. If certain assumptions are met, quasi-experiments can 
generate evidence of causal strength similar to that of RCTs [4]. Empirically, comparisons of 
quasi-experiments and experiments have demonstrated that causal effect size estimates in 
these two types of studies are of similar size  [5-8]. Quasi-experiments are thus a viable 
alternative for causal inference when RCTs are not possible. For this reason, there have 
been recent calls for including quasi-experiments in evidence synthesis [9-12], in particular 
in the field of health systems research where interventions, such as national health care 
reforms, are unlikely to be amenable to RCT-based evaluation.  
However, quasi-experiments are more than just an alternative to consider when RCTs are 
not feasible. Because quasi-experiments combine some of the advantages of investigator-
led and controlled trials with those of non-experimental research, they offer several distinct 
advantages over RCTs. In particular, they avoid some of the threats to external and internal 
validity that can arise in non-blinded RCTs. They are furthermore well-suited to generate 
causal evidence at low cost and on long-term outcomes. Below, we first define quasi-
experiments for the purpose of this article and then discuss five scientific opportunities that 
quasi-experiments offer.  
While quasi-experiments have several advantages over other study designs, they will only 
generate valid inferences when certain assumptions are met that are particular to the 
specific types of quasi-experiments. The assumptions for a number of types of important 
quasi-experiments are described in detail and critically discussed in another article in this 
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themed issue of the Journal of Clinical Epidemiology, on “Quasi-experimental study designs 
for evaluating practice, programs and policies: assessing the assumptions” [4]. Here, we will 
focus on the potential uses and values of quasi-experiments for causal impact evaluation of 
health practice, programs and policies. Other papers in this themed issue discuss why and 
how quasi-experimental results should be included alongside experimental results in 
evidence synthesis [13-18]. 
 
Defining quasi-experiments 
There have been varying definitions of quasi-experiments in the intellectual history of the 
concept [19, 20]. For the purpose of this article, we have chosen the definition by King et al. 
of a quasi-experiment as “an observational study with an exogenous explanatory variable [or 
treatment, or exposure] that the investigator does not control” [21], which is consistent with 
other definitions published in the past two decades [22, 23].  Exogeneity of exposure means 
that the exposure is not influenced by the outcome of interest or any variable that is 
associated with the outcome. Exogeneity of exposure implies that selection bias and 
confounding is controlled for, without needing to observe and explicitly control for any 
confounding factors in the analysis.  
In randomized controlled experiments, exogeneity is achieved through the investigator’s 
randomization of individuals to treatment and control groups. In quasi-experiments, 
exogeneity is plausible for other reasons, including nature, policy, and practice.  The 
credibility of a particular application of a type of quasi-experiment, such as instrumental 
variable or regression discontinuity designs, hinges on the plausibility of key assumptions. 
These assumptions are typically stronger than the assumptions necessary for an RCT to 
generate valid results, but they are also often weaker than the unconfoundedness 
assumption that needs to be met for non-experimental observational to generate unbiased 
inferences [24]. 
According to the above definition, the following study designs are quasi-experimental: 
instrumental variable designs (which identify exogenous variation in a treatment by using a 
variable that is associated with the exposure but is not independently associated with the 
outcome of interest) [25], regression discontinuity designs (which can be used when a 
treatment is assigned according to a threshold rule and exploits exogenous exposure around 
the threshold value of an observed variable) [26, 27], and interrupted time series, as variant 
of regression discontinuity [28]. The definition excludes strategies to identify causal effects 
without exogenous treatment assignment, which cannot control for any unobserved 
confounding factors, such as regression, stratification, or matching studies – i.e., non-
experiments [29].  
Two types of boundary cases are included in the definition: 
• Boundary cases between randomized controlled experiments and quasi-experiments 
are policy experiments which use randomization to allocate individuals to different 
“treatments”, but for purposes other than establishing causal effects and without 
involving scientific investigators in the randomization. For instance, policies are 
sometimes assigned randomly because random assignment is considered a fair 
process, such as in the case of the US Vietnam draft lotter [30, 31].  
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• Boundary cases between quasi-experiments and non-experiments are fixed effects 
studies, including the special case of difference-in-differences (or controlled before-
and-after) studies. These studies can control for some but not all unobserved 
confounding (e.g., unobserved time-invariant but not time-varying confounding [32] or 
unobserved sibling-invariant but not sibling varying confounding [33]), and they have 
thus been called “weak” quasi-experiments [29].  
According to King’s definition, quasi-experiments combine features of experiments 
(exogenous exposure) and non-experiments (observation without an investigator’s 
intervention). In comparison to non-experiments, they thus have the potential to provide 
causal evidence of similar strength to that generated in RCTs; in contrast to RCTs, this 
evidence can be generated in an observational study. As “observational trials”, quasi-
experiments can add substantial value to health research and evidence synthesis. In 
particular, they can establish intervention effects in ‘real life’ – and thus with high external 
validity –, following discovery and RCT-based efficacy testing.  And they can substitute for 
RCTs, when ethics, operational constraints or politics disallow active trial research.  Below, 
we discuss five uses of quasi-experiments to illustrate their value as part of our 
methodological armamentarium, complementing both experiments and non-experiments in 
the quest to establish causal impacts of health practice, programs and policies. 
Use 1: Generating causal evidence when randomized controlled trials are impossible 
Quasi-experiments can often be carried out when evidence on size or magnitude of a causal 
effect are unknown and RCTs cannot be carried out [34]. This situation may arise for ethical, 
operational, or political reasons. 
• Ethical reasons 
One requirement that typically needs to be met for an RCT to be considered ethically 
permissible is equipoise [35], despite criticism of this requirement [36]. Equipoise is 
genuine uncertainty as to whether one treatment is better than another one. In many 
cases, the directionality of a causal effect is known, eliminating equipoise, but the 
magnitude of the causal effect remains uncertain. The magnitude of causal effects is 
important, however, for individual decision-making weighing benefits of a treatment 
against potential harms and for policy-making allocating scarce resources across 
different treatments. Another example when RCTs will unethical, even though causal 
effect size estimates will have value, are trials of harmful exposures. Such trials will 
violate the ethical requirements of “do no harm” and equipoise.  
• Operational reasons 
RCTs may not be practically feasible in many circumstances. In health systems 
research, major interventions commonly occur at the national level, such national 
health systems reforms [37] or health policy changes, such increases in tobacco 
taxation. While causal evidence of these national interventions would be highly 
valuable, it will typically be operationally impossible to randomly assign these 
national interventions to intervention and control groups, because no one can be 
practicably excluded from the intervention.  
• Political reasons 
Even if an RCT is practically feasible an ethically sounds, it may be politically 
unwelcome. For instance, for the evaluation of the national Sure Start program in 
England, the investigators considered an RCT to have been the strongest approach 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
to causal evaluation but could not carry out such a trial because “government 
decisions precluded this possibility” [38]. 
In all three cases, quasi-experiments may provide opportunities to gain strong causal 
evidence when RCTs cannot be carried out. Quasi-experiments are ethically permissible to 
establish the magnitude of causal effect sizes if equipoise has been eliminated, because the 
investigator does not control treatment assignment. For instance, Bor et al. used a 
regression discontinuity approach to quantify for the first time the causal effect of immediate 
vs. deferred antiretroviral treatment on mortality in a sub-Saharan African community [27], 
after it had been firmly established that the treatment was a highly efficacious strategy for 
reducing HIV mortality. Quasi-experiments may also be feasible when randomization is not 
because an intervention cannot be withheld from anyone in country either because it is truly 
national in nature or because policy makers are opposed to random intervention allocation.  
 
Use 2: Generating causal evidence with high degrees of external validity 
Quasi-experiments typically use data on all patients or other “entire” populations across all 
available settings; the data for quasi-experiments is usually collected using routine data 
systems such as clinical records or population census data; and the intervention under study 
in quasi-experiments is normally delivered through real-life systems with routinely available 
resources and in every-day delivery contexts. In contrast, randomized controlled 
experiments select sites and patients and interfere in the intervention processes.   
Quasi-experiments are thus more likely to generate causal evidence that applies to 
intervention implementation in real life. Indeed, a common complaint by clinicians regarding 
evidence from RCTs and evidence synthesis based only on RCTs is that it is unclear 
whether the evidence is relevant to their routine practice [39]. RCTs can lead to externally 
invalid results because of selection effects and “artificiality” introduced at different stages of 
the trial [40]. Selection effects arise because RCTs do not enrol populations that are 
representative of the populations that the trial results are intended to be generalized to. 
Artificiality arises because RCTs include procedures and processes that will not exist in the 
eventual real-life implementation of the RCT-tested intervention. Both selection effects and 
artificiality have several sources.  
Sources of selection effects in RCTs 
• Site selection: RCTs typically take place in a few selected study sites. An upper 
bound of the number of sites included in an RCT is the number of patients to be 
enrolled in the trial, which is constrained because of limited budgets and because the 
ethical obligation to minimize the risk of harm to trial participants implies that the 
number of participants should not exceed the minimum number required to detect 
significant intervention effects. The sample of sites participating in a trial is commonly 
not representative of all sites [41], because site staff need to agree to trial 
participation. In contrast, quasi-experiments are not constrained in sample size 
usually use routine data from all sites where an intervention is provided.  
• Patient selection: RCTs typically apply inclusion and exclusion criteria in selecting 
trial participants, creating systematic differences between trial participants and the 
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population receiving an intervention in real life. Even if a trial does not apply any 
selection criteria, trial participants are likely to be a selected group, because trials 
rely on people volunteering to participate, and the volunteers may not be 
representative of the entire population who will receive an intervention in real life [42, 
43]. In contrast, quasi-experiments normally do not require any selection criteria. 
Sources of artificiality in trials 
• Informed consent process: Participation in RCTs normally requires informed consent 
and the processes leading to informed consent may affect intervention effects. For 
instance, the informed consent process may put more emphasis on adverse events 
and side effects of an intervention than the information given about the intervention in 
routine delivery. Information and other aspects of informed consent processes may 
change the way that trial participants act. For instance, after the informed consent 
process trial participants may be more scared of potential side effects and adverse 
events than they would have been had they received the same intervention in routine 
delivery in the ‘real world’. As a result, trial participants may be less likely to be 
adherent to the intervention than people receiving the intervention in the ‘real world’. 
Quasi-experiments, by contrast, rely on routinely collected data and normally do not 
need to consent people for participation. As a result, they avoid this source of 
artificiality. 
• Delivery processes: RCTs are commonly carried out by adding health workers and 
other resources to routine health systems to manage participant enrolment and to 
collect trial-specific data. Additionally, RCTs typically include other non-routine 
processes, such as frequent provider training and intensified adverse event 
monitoring and follow-up. These enhancements of delivery of care in both 
intervention and control arms of a trial render the trial context different from the ‘real 
world’ context in which an intervention will eventually be delivered (and in which 
quasi-experiments typically take place). These contextual changes threaten the 
external validity of trial results. 
While selection effects and artificiality are likely to threaten external validity to a larger extent 
in experiments than in quasi-experiments, the results from some types of experiments will 
likely be more generalizable than the results from other types. For instance, pragmatic trials 
aim to minimize both selection effects and artificiality, by restricting the number of inclusion 
and exclusion criteria, selecting a wide range of sites for trial participation, and limiting 
interventions in the processes used to deliver an intervention [44]. But even pragmatic trials 
require some infrastructure and some processes that would not exist without the trial and 
may distort the context of intervention delivery. In contrast – because of their observational 
nature – quasi-experiments typically avoid both the selection effects and the artificiality of 
controlled experiments. One important use of quasi-experiments is thus ‘real-life’ 
effectiveness testing following intervention discovery and RCT-based efficacy testing [45]. In 
policy practice, proof of efficacy established in the artificial contexts of RCTs is often 
sufficient to lead to policy adoption of an intervention. In this case, quasi-experiments offer 
opportunities to confirm the intervention effectiveness in routine implementation.  
 
Use 3: Avoiding threats to internal validity that can plague experiments 
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In non-blinded RCTs, internal validity in effect size estimation can be threatened, because 
trial participants react to their assignment to the treatment or the control group. Quasi-
experiments are typically “blinded” and thus avoid such threats.  
• Compensatory rivalry: Subjects in control arms of non-blinded RCTs sometimes 
behave abnormally because social competition motivates them to attempt to reduce 
anticipated treatment effects. Such so-called John Henry effects [46] are unlikely 
when subjects do not know that outcomes are observed and used to establish 
treatment effectiveness, as is generally the case in quasi-experiments.   
• Resentful demoralization: Conversely, subjects in control arms of non-blinded RCTs 
may become resentful of not receiving the intervention the RCT aims to test. As a 
result, they may behave in ways that affects outcomes negatively [47], such as 
ceasing to carry out activities necessary for standard-of-care, leading to an upward 
bias in intervention effect size estimates. Again, in quasi-experimental studies, 
subjects are unlikely to know that outcomes are observed and that they have been 
exogenously “assigned” to treatment and control groups, reducing the likelihood of 
biases due to resentful demoralization.  
In addition, it is sometimes possible to use more than one quasi-experimental approach in 
the same study [48]. Similar results across different quasi-experimental studies will 
strengthen our confidence in the internal validity of findings. 
 
Use 4: Generating evidence on long-term and non-health outcomes 
RCTs in health research commonly assess causal intervention effects over a time horizon of 
only a few years For instance, the vast majority of the more than 100 RCTs that have tested 
interventions to enhance adherence to HIV anti-retroviral treatment ran for five years or less 
and focused on clinical proxy indicators [49, 50]. However, often the effectiveness of an 
intervention over far longer time horizons is important, as in the case of HIV treatment, which 
is life-long. Quasi-experiments typically use routinely collected data and can thus provide 
evidence on causal effects over the long-term beyond typical RCT time horizons. Another 
advantage of basing causal evidence on data that is routinely and continuously collected is 
that causal effects can be repeatedly established as contexts change over time. In particular 
interventions whose effectiveness is likely to depend on contextual factors affected by 
beliefs, attitudes, and habits, such as behavioral interventions [51], may change in their 
(short-term) effects over time, and effect sizes established a long time ago may no longer be 
valid. In this situation, even if theory and non-experimental evidence suggest that 
intervention effects might have changed over time, given strong prior RCT evidence it is 
unlikely that equipoise can be established to ensure ethicality of future RCTs. Quasi-
experiments are well-suited to repeatedly determine causal effects as the distance in time 
from initial RCT-based results increases. Finally, in health research, RCTs typically aim to 
establish causal effects on a few key health outcomes, but are rarely designed to determine 
‘broader’ economic and social outcomes. For policy-making, both within the health sector 
and across sectors, evidence on economic and social causal impacts of health interventions 
is likely to be important [52]. Some interventions – such as the treatments of the chronic 
diseases of old age – may have little impact on a economic and social outcomes, while 
others – such as childhood vaccination – may affect outcomes across a person’s entire life 
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course, including education, income and social functioning. Once an RCT has demonstrated 
primary causal effects of an intervention on health outcomes, future RCTs testing causal 
impact on economic and social outcomes will be unethical, because health interventions of 
proven effectiveness in improving health cannot be ethically withheld from study participants. 
In this case, quasi-experiments offer powerful opportunities to establish causal impacts 
beyond health [53]. 
 
Use 5: Generating evidence fast and at low cost 
As discussed above, quasi-experiments offer several powerful opportunities to increase or 
improve causal evidence when RCTs are either not feasible or are not the right approach for 
generating a particular type of result. Even if RCTs are feasible and the right approach, 
however, quasi-experiments may have potential to contribute to the evidence base. Because 
quasi-experiments are typically retrospective and use routinely collected data, when they are 
possible, they can be a fast and low-cost approach to determine causal effects.  
RCTs are clearly necessary in for efficacy in clinical medicine and, if feasible, should also be 
increasingly carried out to test health practice, programs and policies [54-56]. However, 
RCTs for the real-life causal impact evaluation are frequently expensive and generate results 
only after several years. Quasi-experiments thus offer opportunities for establishing causal 
evidence when such evidence is required quickly [57] or funding for an RCT is unlikely to be 
available.  
 
Discussion 
This paper is in its essence a discussion; however, three particular points warrant a separate 
discussion section: competing terminologies, the uptake of quasi-experiments and 
experiments in different fields of science, replication studies comparing causal estimates 
from randomized to quasi-experimental approaches, and the inclusion of quasi-experimental 
results in evidence synthesis.  
Competing terminologies 
While the term “quasi-experiments” has been commonly used in the way that we use it in 
this article – i.e., an observational study with an exogenous exposure that the investigator 
does not control” [21-23] – other uses of the term have also been common. Importantly, 
some authors have used the word “quasi-experiment” to describe different sets of 
approaches to causal inference. For instance, Greenberg and Schroder call cluster 
randomized controlled trials “quasi-experiments” [58], and Shadish, Cook and Campbell 
define “quasi-experiments” to include all designs that have a “comparison group”, whether 
assignment to intervention and comparison group is exogenous or not [59]. On the other 
hand, some authors, such as Dunning, use the term “natural experiments” to describe 
designs we have called “strong quasi-experiments”: “policy experiments”, regression 
discontinuity designs, and instrumental-variable designs [60]. Given the multitude of 
definitions, researchers using terms such as “quasi-experiments” or “natural experiments” 
need to carefully describe what the mean when using them. While the multitude of definitions 
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and the fact that they typically describe partially overlapping sets of designs can be an 
obstacle to debate and consensus, fundamentally it is not important. What is important is the 
clarity of basic conceptual distinctions in causal inference, in particular, the conceptual 
distinctions between designs that can control for all, some, or no unmeasured confounders.   
Quasi-experiments and experiments 
Quasi-experimental studies have been widely accepted and used in the social sciences for 
several decades [61, 62]. Only more recently, they are also gaining increasing traction in 
health research, in large part because of the opportunities to generate novel and better 
evidence that we discuss above [27, 63-65]. In this context, it is interesting to note that while 
there is a movement to increasingly use quasi-experiments in health research, in the social 
sciences experiments are increasingly becoming a methodological standard.  In neither of 
these broad scientific fields, however, has the adoption of a class of research methods into 
the standard methodological tool set meant a departure from the other class. The social 
sciences are still generating numerous and important research findings using quasi-
experiments, while increasingly also carrying out experiments; the health sciences are 
unlikely to decrease the use of experiments in establishing treatment efficacy of novel 
technologies as the increasingly realize quasi-experimental opportunities for causal 
inference. Rather, the adoption of a new methods class opens up opportunities to answer 
research questions that could not be answered with the previously used class of methods.  
For instance, in the health sciences, an important driver of the use of quasi-experimental 
methods has been the “impact evaluation” agenda [66, 67], which focuses on how to 
establish the “real-life” impact of medical technologies whose efficacy has been established 
in randomized controlled experiments [68, 69].   
An increasing number of studies have compared causal effect size estimates yielded by 
randomized trials to those of non-experimental and quasi-experimental approaches. While a 
comprehensive review of this literature here is beyond the purview of this article, this 
literature suggests that regression discontinuity designs perform well in direct comparisons 
to randomized trials [5-7]. The evidence comparing other types of quasi-experimental and 
non-experimental approaches to randomized trials is more mixed [8, 70], and will depend on 
the degree to which the assumptions of each method are met [71].  
Population-based experiments 
At the same time, in the social sciences so-called population-based experiments have been 
commonly used. Such experiments aim to overcome the external validity limitations of 
“facility-based” experiments by enrolling random samples of well-defined populations in the 
experiment, e.g., all adults in a nation. Population-based experiments have been particularly 
commonly used in population-based survey experiments, in which different questions are 
randomly allocated to respondents as random stimuli [72]. For instance, randomly allocation 
of alternative approaches to frame a question can be used to establish whether the age, sex 
or race of a person displaying a certain behavior matters for the respondent’s evaluation of 
that behavior. However, theoretically many types of stimuli other than survey questions can 
be randomly allocated to entire populations. Population-based experiments are likely to 
eliminate some of the threats to external validity that “facility-based” experiments commonly 
suffer from. In particular, some of the selection processes reducing external validity are 
eliminated when a population-representative sample is visited in their homes and asked to 
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participate in an experiment. Other threats to external validity, however, may persist even if a 
representative sample of an underlying well-defined population participates in an 
experiment. In particular, experiments – whether population- or facility-based – do require an 
intervention that would be absent in “real life”. The intervention and its delivery mechanism 
(e.g., a survey) can change the context in which the intervention effect is measured, 
reducing the strength of our belief that the intervention will have the same effect in “real life” 
that was established in the experiment. 
Encouragement experiments 
One of the major arguments for the increasing attention and use of quasi-experiments – the 
fact that experiments are not ethically permissible when equipoise is violated – can 
sometimes be overcome through the use of so-called encouragement experiments [73, 74]. 
In these studies, a treatment, which is known to be beneficial, is randomly encouraged but 
participants are explicitly allowed to decide whether to receive the treatment or not. 
Examples of encouragements that are randomly allocated in these experiments include 
intensified counselling on the benefits of a treatment, over and above counselling in the 
standard of care, or a financial incentive to take up the treatment. The example of 
encouragement experiments demonstrates again that the definitions of quasi-experiments 
and experiments are fluid and that it is useful to distinguish between identification and 
estimation strategy.  While encouragement experiments are legitimately called experiments 
(because a researcher randomly assigns an exposure), the random exposure assignment 
serves to generate an instrumental variable, i.e., the encouragement can be used as an 
instrument to estimate the causal effect of the encouraged treatment on an outcome of 
interest in an instrumental variable approach.    
Quasi-experiments in evidence synthesis 
The arguments for quasi-experimental studies we outline above are arguments for both 
primary quasi-experimental research and better integration of quasi-experimental results in 
evidence synthesis. In particular, the potential quasi-experiments have to provide strong 
causal evidence when RCTs are not possible; the strength of quasi-experiments in 
producing externally valid results; and the potential quasi-experiments have to establish 
causal effects on long-term and non-health outcomes should be considered when debating 
whether to include quasi-experimental results in the synthesis of a body of evidence.  
Current practices synthesizing bodies of evidence commonly ignore quasi-experimental 
results. Guidelines for evidence synthesis – e.g. the GRADE criteria 
(http://www.gradeworkinggroup.org) – and for reporting of studies – e.g., STROBE 
guidelines – do not make separate recommendations for quasi-experimental studies. Quasi-
experiments are typically graded as observational, non-experimental studies, but this 
assessment does not allow that some quasi-experiments, e.g. regression discontinuity 
designs and randomized natural or policy experiments, yield inferences nearly as strong as 
randomized clinical trials. Furthermore, the features of a rigorously-presented quasi-
experimental study differ from the features of a rigorously-presented cohort or case-control 
study. Devising checklists for the reporting and assessment of quasi-experiments is difficult 
due to the wide range of data generating processes underlying quasi-experiments and the 
wide range of methods used to analyze them [75, 76]. Often, specific subject area 
knowledge is required to determine the plausibility of assumptions invoked in a quasi-
experiment. And yet, the potential of these designs to produce rigorous, actionable evidence 
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to improve patient care, policy design, and resource allocation is too great to be ignored.  
One important area for future research is how to best integrate quasi-experiments into 
methods for evidence synthesis [11, 29]. Stronger integration of quasi-experimental results 
into evidence synthesis may have powerful behavioral feedback effects. The organizations 
that establish standards and guidelines for evidence synthesis, such as the Cochrane 
Collaboration, send signals to primary researchers about what is considered evidence of 
sufficiently high quality and causal strength to influence policy and health care practice. 
Increasing acceptance and consideration of quasi-experiments as a legitimate source of 
causal results for evidence synthesis in health is thus likely to increase the supply of quasi-
experimental evidence. Quasi-experiments have great potential to generate novel and 
important insights, but it is likely that they are currently substantially underutilized relative to 
this potential. Increasing use of quasi-experimental results in evidence synthesis may 
contribute to closing the gap between the potential and the realized contributions of quasi-
experimental studies in informing health care practice, programs and policy. 
Conclusion 
Quasi-experiments offer the practical advantages that they can be carried out when 
randomized experiments are not possible. They have the important advantages that they 
typically generate results that are of higher external validity than experimental results, 
because they take place in ‘real world’ settings rather than in the artificial context of 
experiments. They further avoid the threats to internal validity that arise when participants in 
non-blinded experiments change their behavior in response to the experimental assignment, 
such as compensatory rivalry or resentful demoralization. Quasi-experiments are also well 
suited to establish causal effects on long-term health outcomes, as well as on non-health 
outcomes of a health intervention, such as social and economic consequences. Finally, 
quasi-experiments often generate results faster and at lower costs than experiments. It is 
likely that quasi-experiments will be increasingly used in epidemiology and health systems 
research. Quasi-experimental results should thus be considered and integrated in systematic 
reviews, meta-analyses and other evidence syntheses of causal effects of health care 
practice, programs and policy.    
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